Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

5.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.2K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

1.2K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.2K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

2.5K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.5K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

5.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.7K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

957
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
957
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

7.6K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
7.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Benefits Beyond Hypertension Control: Current and Evolving Treatment Strategies for Prevention of Cardiovascular Diseases.

Current hypertension reviews·2026
Same author

Integrated Management of Cardio-Renal-Metabolic Disorders in India: A Nationwide Physician Survey.

Cureus·2026
Same author

Concurrent diabetes and heart failure: revisiting epidemiological and clinicopathological interplay.

Diabetology international·2026
Same author

Diabetes-Kidney-Heart Continuum and Its Implication on Therapeutic Management.

Cureus·2025
Same author

Expert Consensus Statement on Simplified Glycemic Care in Patients With Type 2 Diabetes Mellitus.

Cureus·2025
Same author

Management of metabolic dysfunction-associated steatotic liver disease (MASLD)-An expert consensus statement from Indian diabetologists' perspective.

Diabetes, obesity & metabolism·2025

Related Experiment Video

Updated: Mar 2, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.4K

Diabetes control during Ramadan fasting.

Raveendran A V1, Abdul Hamid Zargar2,3,4,5

  • 1Specialist in Internal Medicine, Badr Al Samaa, Barka, Sultanate of Oman; Former Assistant Professor of Medicine, Department of Internal Medicine, Govt. Medical College, Manjeri, Malappuram (DT), Kerala, India. raveendranav@yahoo.co.in.

Cleveland Clinic Journal of Medicine
|May 23, 2017
PubMed
Summary
This summary is machine-generated.

Fasting during Ramadan can cause dangerous blood sugar fluctuations for diabetic patients. Proper education, risk assessment, and medication adjustments are key to preventing serious complications.

More Related Videos

Assessment of the Metabolic Effects of Isocaloric 2:1 Intermittent Fasting in Mice
08:06

Assessment of the Metabolic Effects of Isocaloric 2:1 Intermittent Fasting in Mice

Published on: November 27, 2019

9.6K
Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique
07:35

Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique

Published on: January 26, 2024

2.3K

Related Experiment Videos

Last Updated: Mar 2, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.4K
Assessment of the Metabolic Effects of Isocaloric 2:1 Intermittent Fasting in Mice
08:06

Assessment of the Metabolic Effects of Isocaloric 2:1 Intermittent Fasting in Mice

Published on: November 27, 2019

9.6K
Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique
07:35

Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique

Published on: January 26, 2024

2.3K

Area of Science:

  • Endocrinology
  • Metabolic Medicine
  • Islamic Studies

Background:

  • Ramadan fasting presents unique health challenges for individuals with diabetes mellitus.
  • Significant blood glucose variability during Ramadan increases risks of acute metabolic complications.
  • Managing diabetes during Ramadan requires careful consideration of patient-specific factors.

Purpose of the Study:

  • To highlight the risks associated with fasting during Ramadan for diabetic patients.
  • To outline strategies for mitigating acute metabolic complications in this population.
  • To emphasize the importance of medical guidance for diabetic individuals observing Ramadan.

Main Methods:

  • Review of existing literature on diabetes management during Ramadan.
  • Analysis of common acute metabolic complications observed in fasting diabetic patients.
  • Identification of key preventative measures and treatment modifications.

Main Results:

  • Fasting can lead to hypoglycemia, hyperglycemia, diabetic ketoacidosis, dehydration, and thrombosis.
  • Individualized risk stratification is crucial for patient safety.
  • Medication adjustments and patient education are essential for complication reduction.

Conclusions:

  • Diabetic patients fasting during Ramadan face significant health risks.
  • Proactive medical management, including education and medication adjustment, can effectively reduce complication rates.
  • Physicians must be prepared to guide diabetic patients through Ramadan fasting safely.